GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Raphael Pharmaceutical Inc. (CIK0001415397) | 8/14/2026 4:02:23 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Assets $7,000 | EPS $0.01 | ||
| Raphael Pharmaceutical Inc. (CIK0001415397) | 5/14/2026 6:24:00 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Assets $3,000 | EPS $0.01 | ||
| Raphael Pharmaceutical Inc. (CIK0001415397) | 3/31/2026 4:16:05 PM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Assets $53,000 | EPS $0.07 | ||
| Raphael Pharmaceutical Inc. (CIK0001415397) | 11/13/2025 4:13:40 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Assets $7,000 | EPS $0.01 | ||
| Raphael Pharmaceutical Inc. (CIK0001415397) | 8/13/2025 4:14:17 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Assets $30,000 | EPS $0.02 | ||
| Raphael Pharmaceutical Inc. (CIK0001415397) | 5/15/2025 6:25:47 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Assets $93,000 | EPS $0.02 | ||
| Raphael Pharmaceutical Inc. (CIK0001415397) | 3/31/2025 4:16:17 PM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Assets $27,000 | EPS $0.08 | ||
| Raphael Pharmaceutical Inc. (CIK0001415397) | 11/14/2024 4:30:39 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Assets $51,000 | EPS $0.01 | ||
| Raphael Pharmaceutical Inc. (CIK0001415397) | 8/12/2024 4:56:10 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Assets $128,000 | EPS $0.01 | ||
| Raphael Pharmaceutical Inc. (CIK0001415397) | 6/4/2024 4:23:27 PM | View | Proxy | SEC | Y 2023 | ||||||
| Raphael Pharmaceutical Inc. (CIK0001415397) | 5/15/2024 4:17:32 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Assets $353,000 | EPS $0.03 | ||
| Raphael Pharmaceutical Inc. (CIK0001415397) | 3/28/2024 4:38:39 PM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Assets $339,000 | EPS $0.07 | ||
| Raphael Pharmaceutical Inc. (CIK0001415397) | 11/15/2023 4:03:14 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Assets $403,000 | EPS $0.04 | ||
| Raphael Pharmaceutical Inc. (CIK0001415397) | 8/9/2023 4:17:15 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Assets $119,000 | EPS $0.03 | ||
| Raphael Pharmaceutical Inc. (CIK0001415397) | 5/25/2023 4:42:08 PM | Micro | View | Financials | 10-K/A | SEC | Y 2022 ending: 12/31/2022 | Assets $333,000 | EPS $0.23 | ||
| Raphael Pharmaceutical Inc. (CIK0001415397) | 5/15/2023 4:45:01 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Assets $150,000 | EPS $0.02 | ||
| Raphael Pharmaceutical Inc. (CIK0001415397) | 3/24/2023 9:28:26 AM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Assets $333,000 | EPS $0.23 | ||
| Raphael Pharmaceutical Inc. (CIK0001415397) | 11/14/2022 12:09:04 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Assets $121,000 | EPS $0.10 | ||
| Raphael Pharmaceutical Inc. (CIK0001415397) | 8/12/2022 11:56:16 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Assets $196,000 | EPS $0.05 | ||
| Raphael Pharmaceutical Inc. (CIK0001415397) | 5/16/2022 10:27:43 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Assets $180,000 | |||
| Raphael Pharmaceutical Inc. (CIK0001415397) | 3/30/2022 9:39:59 AM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Assets $422,000 | EPS $0.14 | ||
| Raphael Pharmaceutical Inc. (CIK0001415397) | 11/16/2021 3:53:40 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Assets $62,000 | EPS $0.03 | ||
| Easy Energy Inc (CIK0001415397) | 2/17/2009 12:00:00 AM | View | Proxy | SEC |